Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VCNX | Common Stock | Award | $300K | +38.6K | +38.79% | $7.77 | 138K | Mar 28, 2024 | By Vaccinex (Rochester), L.L.C. | F2 |
holding | VCNX | Common Stock | 1.58K | Mar 28, 2024 | Direct | ||||||
holding | VCNX | Common Stock | 1.02K | Mar 28, 2024 | By Jeremy C. Zauderer Trust | F1 | |||||
holding | VCNX | Common Stock | 1.01K | Mar 28, 2024 | By Jordan M. Zauderer Trust | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VCNX | Warrant (Right to Buy) | Award | $300K | +38.6K | $7.77 | 38.6K | Mar 28, 2024 | Common Stock | 38.6K | $7.64 | By Vaccinex (Rochester), L.L.C. | F2 | |
holding | VCNX | Warrant (Right to Buy) | 29.6K | Mar 28, 2024 | Common Stock | 29.6K | $14.00 | By Vaccinex (Rochester), L.L.C. | F2 | |||||
holding | VCNX | Warrant (Right to Buy) | 9.77K | Mar 28, 2024 | Common Stock | 9.77K | $32.76 | By Vaccinex (Rochester), L.L.C. | F2 | |||||
holding | VCNX | Warrant (Right to Buy) | 35.7K | Mar 28, 2024 | Common Stock | 35.7K | $14.00 | By Vaccinex (Rochester), L.L.C. | F2 | |||||
holding | VCNX | Stock Option (Right to Buy) | 12 | Mar 28, 2024 | Common Stock | 12 | $3,129.00 | Direct | F3 | |||||
holding | VCNX | Stock Option (Right to Buy) | 12 | Mar 28, 2024 | Common Stock | 12 | $3,129.00 | Direct | F3 | |||||
holding | VCNX | Stock Option (Right to Buy) | 15 | Mar 28, 2024 | Common Stock | 15 | $1,491.00 | Direct | F3 | |||||
holding | VCNX | Stock Option (Right to Buy) | 135 | Mar 28, 2024 | Common Stock | 135 | $1,402.80 | Direct | F3 | |||||
holding | VCNX | Stock Option (Right to Buy) | 66 | Mar 28, 2024 | Common Stock | 66 | $615.30 | Direct | F4 | |||||
holding | VCNX | Stock Option (Right to Buy) | 133 | Mar 28, 2024 | Common Stock | 133 | $270.90 | Direct | F5 | |||||
holding | VCNX | Stock Option (Right to Buy) | 266 | Mar 28, 2024 | Common Stock | 266 | $92.26 | Direct | F6 | |||||
holding | VCNX | Stock Option (Right to Buy) | 1.88K | Mar 28, 2024 | Common Stock | 1.88K | $9.15 | Direct | F7 |
Id | Content |
---|---|
F1 | Dr. Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. |
F2 | Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
F3 | Exercisable in full as of the date of this report. |
F4 | This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date, except as otherwise provided in the award notice. |
F5 | This option vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date, except as otherwise provided in the award notice. |
F6 | This option vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date, except as otherwise provided in the award notice. |
F7 | This option vests one-fourth on each of the first four anniversaries of the March 20, 2024 grant date, except as otherwise provided in the award notice. |